CRKL Links p210BCR/ABL with Paxillin in Chronic Myelogenous Leukemia Cells
Open Access
- 1 December 1995
- journal article
- Published by Elsevier BV
- Vol. 270 (49), 29145-29150
- https://doi.org/10.1074/jbc.270.49.29145
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Crk Interacts with Tyrosine-phosphorylated p116 upon T Cell ActivationPublished by Elsevier BV ,1995
- SH2 and SH3 domains as molecular adhesives: the interactions of Crk and AblTrends in Biochemical Sciences, 1994
- Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5.The Journal of Experimental Medicine, 1994
- Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.Genes & Development, 1994
- The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity [published erratum appears in J Cell Biol 1994 Mar;124(5):865]The Journal of cell biology, 1994
- SH2 domains recognize specific phosphopeptide sequencesCell, 1993
- Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.JCI Insight, 1992
- Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton.The Journal of cell biology, 1989
- A novel viral oncogene with structural similarity to phospholipase CNature, 1988
- Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemiaNature, 1987